Area of research
Surgery · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Coronary Interventions and Diagnostics, Cardiac Imaging and Diagnostics, Blood Pressure and Hypertension Studies, and Acute Myocardial Infarction Research.
Orbital atherectomy versus balloon angioplasty before drug-eluting stent implantation in severely calcified lesions eligible for both treatment strategies (ECLIPSE): a multicentre, open-label, randomised trial
Long-Term Safety and Efficacy of Renal Denervation: 24-Month Results From the SPYRAL HTN-ON MED Trial
Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis
Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED
Randomized Trials of Renal Denervation for Uncontrolled Hypertension: An Updated Meta‐Analysis
Global Consensus Recommendations on Improving the Safety of Chronic Total Occlusion Interventions
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications
Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications
SCAI Position Statement on Renal Denervation for Hypertension: Patient Selection, Operator Competence, Training and Techniques, and Organizational Recommendations
Provisional Strategy for Left Main Stem Bifurcation Disease
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial
Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents
Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial
Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations
Global Chronic Total Occlusion Crossing Algorithm
Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation
Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension
Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by <scp>SCAI</scp> and <scp>NKF</scp>
A re-examination of the SPYRAL HTN-OFF MED Pivotal trial with respect to the underlying model assumptions
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk
Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization
Management of Percutaneous Coronary Intervention Complications
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies
Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization
Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease
Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no‐reflow during primary PCI: The RESTORE observational study